Multiply Labs develops cloud-controlled robotic systems to manufacture personalized medications on an industrial scale. The company’s mission focuses on setting the gold standard in individualized drug production, leveraging advanced robotics to meet the unique needs of each patient. Founded by two PhD graduates from MIT, the team consists of experts in mechanical engineering, electrical engineering, computer science, software engineering, and pharmaceutical sciences. Based in San Francisco, Multiply Labs operates as a Series A-funded startup, supported by prominent investors in technology and life sciences. The company embodies a collaborative and innovative culture that encourages teamwork and the exchange of ideas, with a commitment to pushing the boundaries at the intersection of robotics and biopharma.